AstraZeneca's Growth Strategy Delivers Amid Booming Demand in China
AstraZeneca is soaring towards its ambitious 2030 sales target fueled by skyrocketing demand for cancer medications and the introduction of new products. With a targeted sales goal of $80 billion.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
